rs763413121
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_003738.5(PTCH2):c.3505delC(p.Leu1169CysfsTer85) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000267 in 1,610,988 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003738.5 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTCH2 | ENST00000372192.4 | c.3505delC | p.Leu1169CysfsTer85 | frameshift_variant | Exon 22 of 22 | 1 | NM_003738.5 | ENSP00000361266.3 | ||
PTCH2 | ENST00000447098.6 | c.3425+80delC | intron_variant | Intron 22 of 22 | 1 | ENSP00000389703.2 | ||||
PTCH2 | ENST00000438067.5 | c.185+80delC | intron_variant | Intron 3 of 4 | 3 | ENSP00000413169.1 |
Frequencies
GnomAD3 genomes AF: 0.0000330 AC: 5AN: 151688Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000798 AC: 20AN: 250492Hom.: 0 AF XY: 0.0000738 AC XY: 10AN XY: 135520
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1459182Hom.: 0 Cov.: 32 AF XY: 0.0000276 AC XY: 20AN XY: 725880
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151806Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74218
ClinVar
Submissions by phenotype
Gorlin syndrome Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 1048946). This variant has not been reported in the literature in individuals affected with PTCH2-related conditions. This variant is present in population databases (rs766993839, gnomAD 0.05%), and has an allele count higher than expected for a pathogenic variant. This sequence change results in a frameshift in the PTCH2 gene (p.Leu1169Cysfs*85). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 35 amino acid(s) of the PTCH2 protein and extend the protein by 49 additional amino acid residues. -
not provided Uncertain:1
The PTCH2 p.Leu1169Cysfs*85 variant was not identified in the literature nor was it identified in ClinVar or LOVD 3.0. The variant was identified in dbSNP (ID: rs766993839), Cosmic and in control databases in 22 of 281788 chromosomes at a frequency of 0.000078 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: Ashkenazi Jewish in 4 of 10294 chromosomes (freq: 0.000389), East Asian in 6 of 19940 chromosomes (freq: 0.000301), Other in 1 of 7202 chromosomes (freq: 0.000139), Latino in 4 of 35406 chromosomes (freq: 0.000113), South Asian in 3 of 30584 chromosomes (freq: 0.000098) and European (non-Finnish) in 4 of 128460 chromosomes (freq: 0.000031), while the variant was not observed in the African or European (Finnish) populations. The c.3505del variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at codon 1169 and leads to a premature stop codon 85 codons downstream. This alteration is then predicted to result in a truncated or absent protein and loss of function. It is currently unclear if loss of function variants of the PTCH2 gene are a mechanism of disease. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at